These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 927284)

  • 41. Comparative potency of atenolol and propranolol as beta-adrenergic blocking agents in man.
    De Plaen JF; Amery A; Reybrouck T
    Eur J Clin Pharmacol; 1976 Sep; 10(5):297-303. PubMed ID: 789082
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Contrasts between pindolol and propranolol concentration-response relationships.
    Carruthers SG; Pacha WL; Aellig WH
    Br J Clin Pharmacol; 1985 Oct; 20(4):417-20. PubMed ID: 4074610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiac and bronchial beta-adrenoceptor antagonistic potencies of atenolol, metoprolol, acebutolol, practolol, propranolol and pindolol in the anaesthetized dog.
    Harms HH; Spoelstra AJ
    Clin Exp Pharmacol Physiol; 1978; 5(1):53-9. PubMed ID: 25152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of pindolol on tachycardia and certain metabolic variations dependent of muscular exertion].
    Cession-Fossion A; Juchmès J; Lecomte J
    Arch Int Physiol Biochim; 1979 Feb; 87(1):95-104. PubMed ID: 92294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
    Conway FJ; Fitzgerald JD; McAinsh J; Rowlands DJ; Simpson WT
    Br J Clin Pharmacol; 1976 Apr; 3(2):267-72. PubMed ID: 973955
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Heart rate and blood pressure responses to intravenous boluses of isoprenaline in the presence of propranolol, practolol and atropine.
    Arnold JM; McDevitt DG
    Br J Clin Pharmacol; 1983 Aug; 16(2):175-84. PubMed ID: 6137231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta-blocking action of bopindolol, a new beta-blocker, and its active metabolites in open chest dogs.
    Okuhira M; Nakazawa M; Kameda H; Hara K; Kawada T; Imai S
    Arch Int Pharmacodyn Ther; 1993; 323():5-15. PubMed ID: 7902696
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of beta blockade with propranolol.
    Hager WD; Pieniaszek HJ; Perrier D; Mayersohn M; Goldberger V
    Clin Pharmacol Ther; 1981 Sep; 30(3):283-90. PubMed ID: 6115730
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of beta-blocking activity of trimepranol in man.
    Pentikäinen PJ; Neuvonen PJ; Penttilä A
    Int J Clin Pharmacol Biopharm; 1978 Jun; 16(6):279-84. PubMed ID: 27464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of pindolol on exercise-induced cardiac acceleration in relation to plasma levels in man.
    Gugler R; Höbel W; Bodem G; Dengler HJ
    Clin Pharmacol Ther; 1975 Feb; 17(2):127-33. PubMed ID: 1122674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative haemodynamic dose-response effects of intravenous propranolol and pindolol in patients with coronary heart disease.
    Silke B; Nelson GI; Ahuja RC; Okoli RC; Taylor SH
    Eur J Clin Pharmacol; 1983; 25(2):157-65. PubMed ID: 6628498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison between the influence of pindolol and propranolol on the response of plasma potassium to catecholamines.
    Castro-Tavares J
    Arzneimittelforschung; 1976 Feb; 26(2):238-41. PubMed ID: 947205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A study of beta-adrenoceptors in the guinea pig.
    Bertholet A; Milavec M; Waite R
    Postgrad Med J; 1981; 57 Suppl 1():9-17. PubMed ID: 6272256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tulobuterol: a full beta-adrenoceptor agonist or a partial beta-agonist with membrane stabilizing activity?
    Gonzalez-Sicilia L; Perez-Ojeda E; Laorden ML; Brugger AJ; Hernandez J
    Gen Pharmacol; 1988; 19(1):103-6. PubMed ID: 2894330
    [TBL] [Abstract][Full Text] [Related]  

  • 56. beta-blockade, atrial natriuretic peptide and exercise.
    Kantola I; Tarssanen L; Scheinin M; Ruskoaho H; Viinamäki O; Kaila T
    Int J Clin Pharmacol Ther; 1996 Jan; 34(1):12-6. PubMed ID: 8688991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estimation of cardiodepressant potency of nadolol, alprenolol, propranolol and pindolol, beta-blocking agents, in heart-lung preparation and blood-perfused excised papillary muscle preparation of the dog.
    Ono H; Kanazawa Y; O'Hara N; Hashimoto K
    Jpn J Pharmacol; 1984 Dec; 36(4):507-17. PubMed ID: 6151997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.
    Coltart DJ; Shand DG
    Br Med J; 1970 Sep; 3(5725):731-4. PubMed ID: 4394650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The antihypertensive action of several beta-adrenoreceptor-blocking drugs.
    Waal-Manning HJ
    N Z Med J; 1976 Apr; 83(561):223-6. PubMed ID: 8748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuro-muscular depressant action of pindolol in comparison with propranolol and procaine.
    Nirmala G; Brahmayya Sastry P
    Arch Int Pharmacodyn Ther; 1979 Apr; 238(2):196-205. PubMed ID: 475508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.